MedGenome - About the company
MedGenome is a series D company based in Bengaluru (India), founded in 2013 by Mahesh Pratapneni and Sam Santhosh. It operates as a Provider of DNA sequencing, bioinformatics, and multiomics services. MedGenome has raised $217M in funding from investors like Peak XV Partners, HDFC and , with a current valuation of ₹707°ä°ù. The company has 146 active competitors, including 28 funded and 28 that have exited. Its top competitors include companies like Foundation Medicine, Personalis and Novogene Corporation.
Company Details
Provider of DNA sequencing, bioinformatics, and multiomics services. This entity offers a comprehensive suite of genomic services, encompassing whole genome and exome sequencing, single-cell sequencing, spatial transcriptomics, and immune profiling. It also provides robust bioinformatics support, including analysis pipelines and data visualization tools, to facilitate research and drug discovery. The services are tailored to support research in various areas, including rare disease research, cancer research, and antibody discovery. A dedicated team of scientists offers expert consultation and project management.
- Website
- Social
- Email ID
- @medgenome.com
- Phone Number
- +91
- Part Of
Key Metrics
Founded Year
2013
Location
Bengaluru, India
Stage
Series D
Total Funding
in 9 rounds
Latest Funding Round
Post Money Valuation
as on Dec 18, 2021
Investors
Ranked
5th among 146 active competitors
Annual Revenue
as on Mar 31, 2023
Employee Count
as on Feb 28, 2025
Investment & Acquisitions
&
Similar Companies
Legal entities associated with MedGenome
MedGenome is associated with 1 legal entity given below:
Legal Entity Name | Date of incorporation | Revenue | Net Profit | Employee Count |
|---|---|---|---|---|
Apr 08, 2013 | $30.6M (as on Mar 31, 2023) | 445 | 263 |
Get your free copy of MedGenome's company profile
MedGenome's funding and investors
MedGenome has raised a total funding of $217M over 9 rounds. Its first funding round was on Aug 20, 2013. Its latest funding round was a Series D round on Aug 30, 2022 for $50M. 3 investors participated in its latest round, which includes Novo Holdings, ATEL Capital Group, IFC and Sofina.
MedGenome has 19 institutional investors including Peak XV Partners, HDFC and . There are 11 Angel Investors in MedGenome.
Here is the list of recent funding rounds of MedGenome:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
|---|---|---|---|---|---|
Aug 30, 2022 | $50M | Series D | 3958956 | 6354589 | Novo Holdings, Sofina, and |
Jul 15, 2021 | $16.5M | Series D | 7486235 | 5534448 | IFC, |
Apr 01, 2020 | $55M | Series D | 5871088 | 7300893 | LeapFrog Investments, Sofina, and |
Access funding benchmarks and valuations. Sign up today!View details of MedGenome's funding rounds and investors
MedGenome's valuation details
MedGenome is valued at $93M as per the latest available filings. Here is MedGenome's valuation trend over time:
Date | Valuation |
|---|---|
Dec 21 | $93M |
Jun 19 | 107 |
Jul 18 | 797 |
Mar 18 | 221 |
Aug 17 | 810 |
See how MedGenome's valuation has changed over time. Sign up today!MedGenome's founders and board of directors
The founders of MedGenome are Mahesh Pratapneni and Sam Santhosh. Mahesh Pratapneni and are the CEO of MedGenome. Sam Santhosh has founded 8 more companies including , and Calsoft. Mahesh Pratapneni has founded 1 more company - .
MedGenome's board has 5 active members. Mahesh Pratapneni and Sam Santhosh are part of team and , and are independent board members.
View details of MedGenome's Founder profiles and Board Members
MedGenome's employee count trend
MedGenome has 899 employees as of Feb 25. The total employee count is 0.2% more than what it was in Feb 24. Here is MedGenome's employee count trend over the years:
Uncover MedGenome's growth story! Sign up today!MedGenome's Competitors and alternates
Top competitors of MedGenome include Foundation Medicine, Personalis and Novogene Corporation. Here is the list of Top 10 competitors of MedGenome, ranked by ÃØÃÜÑо¿Ëù score :
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
|---|---|---|---|---|---|
1st | Foundation Medicine 2010, Cambridge (United States), Acquired | Provider of genomics-based diagnostics test for cancer | $96.5M | Ridgeback Capital Management, Kleiner PerkinsÌý&²¹³¾±è;Ìý | 76/100 |
2nd | Personalis 2011, Menlo Park (United States), Public | Provider of genomic sequencing and diagnosis software for the healthcare industry | $87.3M | Abingworth, Mohr Davidow VenturesÌý&²¹³¾±è;Ìý | 70/100 |
3rd | Novogene Corporation 2011, Beijing (China), Series B | Provider of genomic services and solutions | $75M | , China Merchants CapitalÌý&²¹³¾±è;Ìý | 65/100 |
4th |  Lantern Pharma 2013, Dallas (United States), Public | Developing drug and companion diagnostics for multi-drug resistant cancers | $7.12M | Green Park & Golf Ventures, Bios PartnersÌý&²¹³¾±è;Ìý | 64/100 |
5th |  2013, Bengaluru (India), Series D | Provider of DNA sequencing, bioinformatics, and multiomics services | $217M | Novo Holdings, ATEL Capital GroupÌý&²¹³¾±è;Ìý | 61/100 |
6th | Burning Rock 2014, Guangzhou (China), Series C | Developer of personalised diagnostic and treatment services based on genomic big data analysis | $203M | 63/100 | |
7th | Zhejiang Nuhui Health Technology 2013, Beijing (China), Public | Provider of early cancer screening and testing services | $152M | Orbimed, Rock Springs CapitalÌý&²¹³¾±è;Ìý | 63/100 |
8th | _1584017279218.png?height=40&width=40){kind=logo} Veritas Genetics 2014, Danvers (United States), Acquired | Provider of genetic testing products | $53.4M | Trustbridge Partners, MassVenturesÌý&²¹³¾±è;Ìý | 62/100 |
9th | NGeneBio 2015, Seoul (South Korea), Public | In vitro cancer diagnostic products | $12.9M | Korea Investment Holdings, IMM InvestmentÌý&²¹³¾±è;Ìý | 59/100 |
10th | 3billion 2016, Seoul (South Korea), Public | Provider of AI-driven clinical diagnostic testing platform for rare genetics disease | $25.7M | Yuanta Investment, Korean Development BankÌý&²¹³¾±è;Ìý | 57/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on MedGenome's competitors? Click to see the top ones
MedGenome's Investments and acquisitions
MedGenome has acquired 3 companies including , and Lifecode. MedGenome has not made any investments as of now. Here is the list of its acquisitions:
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
May 26, 2023 | Acquisition |  | 2002 | Delhi, India |
Nov 23, 2021 | Acquisition | | - | |
Feb 24, 2016 | Acquisition | - |
Want to know more about where corporates are investing? Sign up today!See all acquisitions by MedGenome
Reports related to MedGenome
Here is the latest report on MedGenome's geography:
View
News related to MedGenome
Media has covered MedGenome for a total of 7 events in the last 1 year, 4 of them have been about people movement and 1 about company updates.
•
•
•
•
•
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Frequently asked questions about MedGenome
When was MedGenome founded?
MedGenome was founded in 2013.Where is MedGenome located?
MedGenome is located in Bengaluru, India.Is MedGenome a funded company?
MedGenome is a funded company, its first funding round was on Aug 20, 2013.When was the latest funding round of MedGenome?
MedGenome's latest funding round was on Aug 30, 2022.How much is MedGenome worth?
The latest valuation of MedGenome is ₹707°ä°ù as on Dec 18, 2021.What is the annual revenue of MedGenome?
Annual revenue of MedGenome is ₹246°ä°ù as on Mar 31, 2023.Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies- 212K+ Investors
- 580K+ Funding Rounds
- 207K+ Acquisitions
- 2.9K+ Sectors
- 57K+ Business Models
Are you a Founder ?
Explore our recently published companies
- Pragathi International - Bengaluru based, 2009 founded, Unfunded company
- Park Lane Advice Group - Melbourne based, 2020 founded, Unfunded company
- AlgoSurg - Wilmington based, 2018 founded, Funding Raised company
- The BB Cream Girl - Dubai based, 2012 founded, Unfunded company
- Siembra la Tierra - Jayuya based, 2020 founded, Funding Raised company
- Jindus Specialty Chemicals - Delhi based, 2015 founded, Unfunded company
